Compare STAA & BTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STAA | BTZ |
|---|---|---|
| Founded | 1982 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | N/A |
| Metric | STAA | BTZ |
|---|---|---|
| Price | $17.54 | $10.69 |
| Analyst Decision | Hold | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $23.53 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 279.4K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.40% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.41 |
| Revenue | ★ $230,591,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.19 | N/A |
| P/E Ratio | ★ N/A | $7.57 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.50 | $9.10 |
| 52 Week High | $30.81 | $11.13 |
| Indicator | STAA | BTZ |
|---|---|---|
| Relative Strength Index (RSI) | 25.90 | 55.30 |
| Support Level | $16.94 | $10.56 |
| Resistance Level | $19.54 | $10.86 |
| Average True Range (ATR) | 0.78 | 0.05 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 12.24 | 97.71 |
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.